ArticlebioRxiv : the preprint server for biology2026
Endocrine therapy-specific lineage and partial epithelial-mesenchymal reprogramming defines divergent resistant cell-states in ER+ breast cancer.
Sarthak Sahoo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.